Sex differences in cardiovascular morbidity associated with familial hypercholesterolaemia: A retrospective cohort study of the UK Simon Broome register linked to national hospital records

[1]  B. Nordestgaard,et al.  Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects. , 2020, Journal of the American College of Cardiology.

[2]  U. Julius,et al.  Efficiency and problems of statin therapy in patients with heterozygous familial hypercholesterolemia. , 2019, Atherosclerosis. Supplements.

[3]  S. Humphries,et al.  Risk of cardiovascular disease outcomes in primary care subjects with familial hypercholesterolaemia: A cohort study. , 2019, Atherosclerosis.

[4]  Leo Ungar,et al.  Percutaneous Coronary Intervention in Familial Hypercholesterolemia Is Understudied , 2018, Front. Cardiovasc. Med..

[5]  S. Humphries,et al.  Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register , 2018, Atherosclerosis.

[6]  J. Versmissen,et al.  Sex differences in cholesterol levels from birth to 19 years of age may lead to increased cholesterol burden in females with FH. , 2018, Journal of clinical lipidology.

[7]  G. Tell,et al.  Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia , 2018, Heart.

[8]  Emily C. O'Brien,et al.  Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry. , 2017, Atherosclerosis.

[9]  N. Wenger,et al.  Comprehensive primary prevention of cardiovascular disease in women , 2017, Clinical cardiology.

[10]  J. Marrugat,et al.  Familial hypercholesterolemia in a European Mediterranean population-Prevalence and clinical data from 2.5 million primary care patients. , 2017, Journal of clinical lipidology.

[11]  S. Humphries,et al.  Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK , 2017, European heart journal.

[12]  D. Wald,et al.  Child-Parent Familial Hypercholesterolemia Screening in Primary Care. , 2016, The New England journal of medicine.

[13]  D. Lloyd‐Jones,et al.  Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype , 2016, Circulation.

[14]  I. Petersen,et al.  Time trends in the prescription of statins for the primary prevention of cardiovascular disease in the United Kingdom: a cohort study using The Health Improvement Network primary care data , 2016, Clinical epidemiology.

[15]  I. Petersen,et al.  Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study , 2016, BMJ Open.

[16]  Catherine Boileau,et al.  Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease , 2013, European heart journal.

[17]  S. Humphries,et al.  Current statin treatment, DNA testing and cascade testing of UK patients with familial hypercholesterolaemia , 2012 .

[18]  F. Magkos,et al.  Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones. , 2011, The Journal of clinical endocrinology and metabolism.

[19]  Y. Appelman,et al.  Gender differences in coronary heart disease , 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[20]  S. Humphries,et al.  Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study. , 2005, Atherosclerosis.

[21]  S. Humphries,et al.  Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia , 2004, Heart.

[22]  Carolyn M Hutter,et al.  Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. , 2004, American journal of epidemiology.

[23]  S. Humphries,et al.  A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. , 2003, Atherosclerosis.

[24]  M. Shinomiya,et al.  Characteristic Features of Long‐Living Patients with Familial Hypercholesterolemia in Japan , 1993, Journal of the American Geriatrics Society.

[25]  Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. , 1991, BMJ.

[26]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.